RELCHAYNE Trademark

Trademark Overview

On Tuesday, July 21, 2015, a trademark application was filed for RELCHAYNE with the United States Patent and Trademark Office. The USPTO has given the RELCHAYNE trademark a serial number of 79173613. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 23, 2022. This trademark is owned by CSL Behring Recombinant Facility AG. The RELCHAYNE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment or prevention of blood and bleeding disorders; blood for medical purposes; blood proteins for therapeutic use; pharmaceutical blood products derived from recombinant DNA technology for medical purposes
relchayne

General Information

Serial Number79173613
Word MarkRELCHAYNE
Filing DateTuesday, July 21, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 23, 2022
Registration Number4971106
Registration DateTuesday, June 7, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2016

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment or prevention of blood and bleeding disorders; blood for medical purposes; blood proteins for therapeutic use; pharmaceutical blood products derived from recombinant DNA technology for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCSL Behring Lengnau AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameCSL Behring Recombinant Facility AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameCSL Behring Recombinant Facility AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, October 3, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, September 13, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, September 13, 2023INVALIDATION PROCESSED
Wednesday, August 23, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 23, 2022CANCELLED SECTION 71
Friday, September 2, 2022NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 7, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, April 26, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 26, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 22, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, December 18, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 18, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 10, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 28, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 18, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 10, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 16, 2016NEW REPRESENTATIVE AT IB RECEIVED
Sunday, October 2, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 12, 2016FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 12, 2016FINAL DISPOSITION PROCESSED
Wednesday, September 7, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, July 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 7, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, March 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2016PUBLISHED FOR OPPOSITION
Friday, March 18, 2016NOTIFICATION PROCESSED BY IB
Wednesday, March 2, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 2, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 8, 2016EXAMINER'S AMENDMENT ENTERED
Monday, February 8, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 8, 2016EXAMINERS AMENDMENT E-MAILED
Monday, February 8, 2016EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 27, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 27, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 4, 2015REFUSAL PROCESSED BY IB
Thursday, November 12, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 12, 2015REFUSAL PROCESSED BY MPU
Saturday, November 7, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 6, 2015NON-FINAL ACTION WRITTEN
Saturday, October 31, 2015ASSIGNED TO EXAMINER
Tuesday, October 13, 2015APPLICATION FILING RECEIPT MAILED
Friday, October 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 8, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

relchayne blood medical purposes derived products from recombinant technology pharmaceutical therapeutic